>
Curasight A/S logo

CURAS TO 1 - Curasight A/S Share Price

DKK3.3 0.0  0.0%

Last Trade - 05/10/21

Sector
Healthcare
Size
Micro Cap
Market Cap £6.41m
Enterprise Value £2.54m
Revenue £-614k
Position in Universe 1717th / 1864
Bullish
Bearish
Unlock CURAS TO 1 Revenue
Momentum
Relative Strength (%)
1m -55.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -83.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 -0.99 -0.37 -0.74 0.026
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2021, Curasight A/Srevenues decreased from -DKR147K to -DKR772K. Net lossincreased from DKR439K to DKR1.6M. Revenues reflect adecrease in demand for the Company's products and servicesdue to unfavorable market conditions. Higher net lossreflects Depreciation/Amortization increase from DKR37K toDKR516K (expense), Staff expenses increase of 73% toDKR654K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CURAS TO 1 Revenue Unlock CURAS TO 1 Revenue

Net Income

CURAS TO 1 Net Income Unlock CURAS TO 1 Revenue

Normalised EPS

CURAS TO 1 Normalised EPS Unlock CURAS TO 1 Revenue

PE Ratio Range

CURAS TO 1 PE Ratio Range Unlock CURAS TO 1 Revenue

Dividend Yield Range

CURAS TO 1 Dividend Yield Range Unlock CURAS TO 1 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CURAS TO 1 EPS Forecasts Unlock CURAS TO 1 Revenue
Profile Summary

Curasight A/S is a clinical development company based in Copenhagen, Denmark. The Company is a pioneer in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). The technology provides improved diagnosis and risk stratification in multiple cancer types.

Directors
Last Annual December 31st, 2020
Last Interim June 30th, 2021
Incorporated May 22, 2013
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange AktieTorget Stock Exchange (Dual Listing)
Shares in Issue 17,126,340
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CURAS TO 1 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CURAS TO 1
Upcoming Events for CURAS TO 1
Frequently Asked Questions for Curasight A/S
What is the Curasight A/S share price?

As of 05/10/21, shares in Curasight A/S are trading at DKK3.3, giving the company a market capitalisation of £6.41m. This share price information is delayed by 15 minutes.

How has the Curasight A/S share price performed this year?

Shares in Curasight A/S are currently trading at DKK3.3 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Curasight A/S price has moved by % over the past year.

What are the analyst and broker recommendations for Curasight A/S?

There are no analysts currently covering Curasight A/S.

When will Curasight A/S next release its financial results?

Curasight A/S is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Curasight A/S dividend yield?

Curasight A/S does not currently pay a dividend.

Does Curasight A/S pay a dividend?

Curasight A/S does not currently pay a dividend.

When does Curasight A/S next pay dividends?

Curasight A/S does not currently pay a dividend.

How do I buy Curasight A/S shares?

To buy shares in Curasight A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Curasight A/S?

Shares in Curasight A/S are currently trading at DKK3.3, giving the company a market capitalisation of £6.41m.

Where are Curasight A/S shares listed? Where are Curasight A/S shares listed?

Here are the trading details for Curasight A/S:

Country of listing: Sweden
Exchange: AKT
Ticker Symbol: CURAS TO 1
What kind of share is Curasight A/S?

Based on an overall assessment of its quality, value and momentum, Curasight A/S is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Curasight A/S share price forecast 2021?

We were not able to load any forecast data for Curasight A/S.

How can I tell whether the Curasight A/S share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Curasight A/S. Over the past six months, the relative strength of its shares against the market has been -67.58%. At the current price of DKK3.3, shares in Curasight A/S are trading at -65.03% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Curasight A/S PE Ratio?

We were not able to find PE ratio data for Curasight A/S.

Who are the key directors of Curasight A/S?

Curasight A/S's management team is headed by:

Andreas Kjaer - CFD
Ulrich Krasilnikoff - CEO
Lars Trolle - VCH
Per Falholt - CHM
Charlotte Vedel - DRC
Jacob Madsen - CFD
Carsten Nielsen - CFD
Who are the major shareholders of Curasight A/S?

Here are the top five shareholders of Curasight A/S based on the size of their shareholding:

Similar to CURAS TO 1
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.